Publications by authors named "Jan Peter van Kuijk"

Claim this Profile
C
Clinical outcomes of the BioMime™ morph coronary stent system for long (30 to ≤56 mm length) coronary lesions: Three-year follow-up of the Morpheus Global Registry.
Pierfrancesco Agostoni, Jan-Peter Van Kuijk, Paul Knaapen, Farhat Fouladvand, Martin Hudec

Cardiovasc Revasc Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial.
Ruben W de Winter, Roel Hoek, Simon J Walsh, Colm G Hanratty, Ralf W Sprengers, Jan-Peter van Kuijk

J Am Coll Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary sinus narrowing for the treatment of refractory angina: one-year results of the REDUCER-I study.
Stefan Verheye, Tim P van de Hoef, Ranil de Silva, Jan-Peter van Kuijk, Jonathan Byrne

EuroIntervention· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-risk plaques in non-culprit lesions and clinical outcome after NSTEMI vs. STEMI.
Rick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Jan-Peter van Kuijk

Eur Heart J Cardiovasc Imaging· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Sinus Narrowing for Treating Refractory Angina: REDUCER-I Multicenter "Real-World" Observational Study Primary Endpoint Analysis.
Stefan Verheye, Tim P van de Hoef, Ranil de Silva, Jan-Peter van Kuijk, Jonathan Byrne

JACC Cardiovasc Interv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.
Rick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Jan-Peter van Kuijk

Atherosclerosis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled Trial.
Pieter C Smits, Pim A L Tonino, Sjoerd H Hofma, Jan-Peter van Kuijk, Fabrizio Spano

Circ Cardiovasc Interv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial.
Tom A Meijers, Alexander Nap, Adel Aminian, Thomas Schmitz, Joseph Dens, Jan-Peter van Kuijk

EuroIntervention· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications of Balloon Pulmonary Angioplasty: A Comprehensive Analysis Based on the Latest ESC Consensus Statement.
Fe J van Leusden, Diederik P Staal, Mitch C J van Thor, Benno J M W Rensing, Jan-Peter van Kuijk

J Clin Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding Surgical Edge-to-Edge Mitral Valve Repair to Myectomy in Hypertrophic Obstructive Cardiomyopathy: Long-Term Functional and Echocardiographic Outcome.
Romy R M J J Hegeman, Tijn Heeringa, Sophie H Q Beukers, Jan Peter Van Kuijk, Marco Guglielmo

Curr Probl Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
Daimy M M Dillen, Pieter Jan Vlaar, Amy J E Vermeer, Valeria Paradies, Jan-Peter van Kuijk

Am Heart J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional Flow Reserve-Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction.
Jan-Quinten Mol, Rick H J A Volleberg, Anouar Belkacemi, Renicus S Hermanides, Martijn Meuwissen, Jan-Peter van Kuijk

JAMA Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Supraflex Cruz 60 μm Versus Ultimaster Tansei 80 μm Stent Struts in High Bleeding Risk PCI Patients: Study design and Rational of Compare 60/80 HBR trial.
Valeria Paradies, Matteo Maurina, Pim Tonino, Sjoerd H Hofma, Jeroen Vos, Jan-Peter van Kuijk

Am J Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world impact of added FFR-CT to coronary CT angiography on clinical decision-making and patient prognosis - IMPACT FFR study.
Leonie M Becker, Joyce Peper, Bram J L A Verhappen, Laurens A Swart, Admir Dedic, Jan-Peter van Kuijk

Eur Radiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inward Displacement: A Novel Method of Regional Left Ventricular Functional Assessment for Left Ventriculoplasty Interventions in Heart Failure with Reduced Ejection Fraction (HFrEF).
Romy R M J J Hegeman, Sean McManus, Jan-Peter van Kuijk, Serge C Harb, Martin J Swaans

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
ULTrasound-guided TRAnsfemoral puncture in COmplex Large bORe PCI: study protocol of the UltraCOLOR trial.
Thomas A Meijers, Alexander Nap, Adel Aminian, Joseph Dens, Koen Teeuwen, Jan-Peter van Kuijk

BMJ Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midterm Outcome of Hybrid Transcatheter and Minimally Invasive Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure.
Romy R M J J Hegeman, Martin J Swaans, Jan-Peter Van Kuijk, Patrick Klein

Struct Heart· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State-of-the-Art Review: Technical and Imaging Considerations in Hybrid Transcatheter and Minimally Invasive Left Ventricular Reconstruction for Ischemic Heart Failure.
Romy Roosmarijn Maria Jacqueline Josepha Hegeman, Martin John Swaans, Jan-Peter van Kuijk, Patrick Klein

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus.
Giovanni M Vescovo, Carlo Zivelonghi, Pierfrancesco Agostoni, Mirthe Dekker, Max Silvis, Jan Peter van Kuijk

Heart Vessels· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional Flow Reserve: Patient Selection and Perspectives.
Joyce Peper, Leonie M Becker, Jan-Peter van Kuijk, Tim Leiner, Martin J Swaans

Vasc Health Risk Manag· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study.
Francesco Ponticelli, Arif A Khokhar, Geert Leenders, Maayan Konigstein, Carlo Zivelonghi, Jan-Peter van Kuijk

Int J Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs study.
Jan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, Martijn Meuwissen, Alexey V Protopopov, Jan-Peter van Kuijk

BMJ Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary sinus anatomical features: Description and procedural implications during coronary sinus Reducer implantation.
Adriaan Wilgenhof, Carlo Zivelonghi, Stefan Verheye, Paul Vermeersch, Benjamin Scott, Jan Peter Van Kuijk

Catheter Cardiovasc Interv· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio-FFR revascularization decision-making strategy.
Joyce Peper, Robbert W van Hamersvelt, Benno J W M Rensing, Jan-Peter van Kuijk, Michiel Voskuil

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Coronary Sinus Reducer in Patients With Non-revascularized Chronic Total Occlusions.
Carlo Zivelonghi, Stefan Verheye, Leo Timmers, Jan Peter van Kuijk, Francesco Giannini

Am J Cardiol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis